Ironwood Pharmaceuticals | Zysk Brutto Na Sprzedaży



Gross Profit On Sales Zmiana Data
Acadia Pharmaceuticals USD 237.8M 72.86M 2024-12
Agios Pharmaceuticals USD 9.47M 1.29M 2024-12
Almirall EUR 231.69M 73.09M 2024-06
Alnylam Pharmaceuticals USD 490.35M 75.33M 2024-12
Amarin USD 16.28M 26.49M 2024-09
Ardelyx USD 97.86M 15.35M 2024-12
Astellas Pharma JPY 418.89B 39.08B 2024-12
AstraZeneca USD 12.17B 1.06B 2024-12
Charles River Laboratories USD 319.68M 48.09M 2024-12
Exact Sciences USD 429.29M 83.29M 2024-12
Halozyme Therapeutics USD 255.95M 15.3M 2024-12
Incyte USD 1.1B 38.34M 2024-12
Ironwood Pharmaceuticals USD 3.65M 60.36M 2024-09
MacroGenics USD 108.84M 100.86M 2024-09
Moderna USD 420M 1.14B 2024-12
Myriad Genetics USD 150.9M 1.1M 2024-12
Pacira USD 147.37M 17.66M 2024-12
PTC Therapeutics USD 196.89M 10.95M 2024-12
Sarepta Therapeutics USD 526.11M 150.63M 2024-12
Takeda JPY 727.25B 54.48B 2024-12
Ultragenyx Pharmaceutical USD 147.98M 29.51M 2024-12



Ironwood Pharmaceuticals Zysk Brutto Na Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.